ArticleTrials2023

SMA-TB: study protocol for the phase 2b randomized double-blind, placebo-controlled trial to estimate the potential efficacy and safety of two repurposed drugs, acetylsalicylic acid and ibuprofen, for use as adjunct therapy added to, and compared with, the standard WHO recommended TB regimen.

Lilibeth Arias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.